Table 3.
Antimicrobial susceptibility profiles of methicillin-susceptible Staphylococcus aureus (MSSA) and methicillin-resistant S. aureus (MRSA) isolates.
| S. aureus (n = 78), Ra (%) | MRSA (n = 27), Ra (%) | MSSA (n = 51), Ra (%) | P-valueb | |
|---|---|---|---|---|
| FOX | 34.6 | 100 | 0 | < 0.05 |
| LZD | 0 | 0 | 0 | |
| CIP | 5.1 | 3.7 | 5.9 | > 0.05 |
| DA | 44.9 | 63 | 35.3 | < 0.05 |
| E | 46.2 | 63 | 37.3 | < 0.05 |
| SXT | 9 | 3.7 | 11.8 | > 0.05 |
| MOF | 1.3 | 3.7 | 0 | > 0.05 |
| V | 0 | 0 | 0 | |
| TET | 23.1 | 29.6 | 19.6 | > 0.05 |
| P | 93.6 | 100 | 90.2 | > 0.05 |
| RD | 1.3 | 3.7 | 0 | > 0.05 |
| LEV | 2.6 | 7.4 | 0 | < 0.05 |
| OXA | 34.6 | 100 | 0 | < 0.05 |
| GM | 3.8 | 3.7 | 3.9 | > 0.05 |
| Q/D | 0 | 0 | 0 |
aR = resistance. bThe resistance rates of antimicrobials among MRSA strains were compared to those among MSSA isolates. Cefoxitin (FOX), linezolid (LZD), ciprofloxacin (CIP), clindamycin (DA), erythromycin (E), trimethoprim-sulfamethoxazole (SXT), moxifloxacin (MOF), vancomycin (V), tetracycline (TET), penicillin (P), rifampicin (RF), levofloxacin (LVX), oxacillin (OXA), gentamicin (GM), quinupristin/dalfopristin (Q/D), and tigecycline (TGC).